Risk Factors of Hemophagocytic Lymphohistiocytosis in Adults with Fever of Unknown Origin: A Retrospective Study

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Date 2025 Jan 28

PMID 39872968

Authors

Fangbing Tian

Nana Xie

Wenjin Sun

Wencong Zhang

Wenyuan Zhang

Jia Chen

Qiurong Ruan

Jianxin Song

Affiliations

Soon will be listed here.

Abstract

Purpose: Hemophagocytic lymphohistiocytosis (HLH) is a critical syndrome with a high mortality rate. In clinical practice, some patients with fever of unknown origin (FUO) can develop HLH, further complicating the diagnosis and treatment. However, studies on HLH in adults with FUO are limited. This study aimed to investigate the clinical characteristics of adult patients with FUO to facilitate the early identification of those at high risk of developing HLH.

Patients And Methods: We collected data from hospitalized patients with FUO between January 2014 and December 2020. Risk factors for HLH in adults with FUO were analyzed using univariate and multivariate analysis.

Results: A total of 988 patients with FUO were included in the study. The incidence of HLH in adults with FUO was 6.4%, with hematological tumors being the primary cause. Multivariate analysis indicated that skin rash and elevated alanine aminotransferase, total bilirubin, triglycerides, lactate dehydrogenase, and ferritin levels were independent risk factors for HLH in adults with FUO.

Conclusion: This study revealed the incidence rate, etiology distribution, and risk factors for HLH in adults with FUO. Comprehensive assessment of clinical and laboratory data at admission can assist in the early identification of FUO patients at risk for HLH.

References

Wright W, Mulders-Manders C, Auwaerter P, Bleeker-Rovers C . Fever of Unknown Origin (FUO) - A Call for New Research Standards and Updated Clinical Management. Am J Med. 2021; 135(2):173-178. DOI: 10.1016/j.amjmed.2021.07.038. View

Khan S, Naim F, Ullah H, Niaz F, Bilal M . Hemophagocytic Lymphohistiocytosis: A Rare Cause of Pyrexia of Unknown Origin. Cureus. 2022; 14(3):e23368. PMC: 9020787. DOI: 10.7759/cureus.23368. View

Ul Haque W, Shuvo M, Rahim M, Mitra P, Samad T, Haque J . Haemophagocytic syndrome in an adult suffering from pyrexia of unknown origin: an uncommon presentation of tuberculosis: a case report. BMC Res Notes. 2017; 10(1):110. PMC: 5327568. DOI: 10.1186/s13104-017-2434-y. View

West J, Stilwell P, Liu H, Ban L, Bythell M, Card T . Temporal Trends in the Incidence of Hemophagocytic Lymphohistiocytosis: A Nationwide Cohort Study From England 2003-2018. Hemasphere. 2022; 6(11):e797. PMC: 9624441. DOI: 10.1097/HS9.0000000000000797. View

Yildiz H, Van den Neste E, Defour J, Danse E, Yombi J . Adult haemophagocytic lymphohistiocytosis: a Review. QJM. 2020; . DOI: 10.1093/qjmed/hcaa011. View

Shi X, Liu X, Zhou B, Zhang L, Ma X, Deng G . Major causes of fever of unknown origin at Peking Union Medical College Hospital in the past 26 years. Chin Med J (Engl). 2013; 126(5):808-12. View

Ho C, Yao X, Tian L, Li F, Podoltsev N, Xu M . Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am J Clin Pathol. 2013; 141(1):62-71. DOI: 10.1309/AJCPMD5TJEFOOVBW. View

Al-Samkari H, Berliner N . Hemophagocytic Lymphohistiocytosis. Annu Rev Pathol. 2017; 13:27-49. DOI: 10.1146/annurev-pathol-020117-043625. View

Wright W, Auwaerter P . Fever and Fever of Unknown Origin: Review, Recent Advances, and Lingering Dogma. Open Forum Infect Dis. 2020; 7(5):ofaa132. PMC: 7237822. DOI: 10.1093/ofid/ofaa132. View

10.

Griffin G, Shenoi S, Hughes G . Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020; 34(4):101515. DOI: 10.1016/j.berh.2020.101515. View

11.

Schram A, Campigotto F, Mullally A, Fogerty A, Massarotti E, Neuberg D . Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015; 125(10):1548-52. DOI: 10.1182/blood-2014-10-602607. View

12.

Amisha , Malik P, Pathania M, Rathaur V, Kaeley N . Hemophagocytic lymphohistiocytosis as a diagnostic consideration of fever of unknown origin with pancytopenia and chronic liver disease. J Family Med Prim Care. 2019; 8(4):1504-1507. PMC: 6510086. DOI: 10.4103/jfmpc.jfmpc_190_19. View

13.

Cheng W, Xu J, Shu Y, Qiu H, Yin G . Association of a decreased platelet count with poor survival in patients with adult secondary hemophagocytic lymphohistiocytosis. Ann Hematol. 2024; 103(4):1159-1166. DOI: 10.1007/s00277-024-05663-6. View

14.

Okabe T, Shah G, Mendoza V, Hirani A, Baram M, Marik P . What intensivists need to know about hemophagocytic syndrome: an underrecognized cause of death in adult intensive care units. J Intensive Care Med. 2011; 27(1):58-64. DOI: 10.1177/0885066610393462. View

15.

Knaak C, Nyvlt P, Schuster F, Spies C, Heeren P, Schenk T . Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore. Crit Care. 2020; 24(1):244. PMC: 7245825. DOI: 10.1186/s13054-020-02941-3. View

16.

Unger M, Karanikas G, Kerschbaumer A, Winkler S, Aletaha D . Fever of unknown origin (FUO) revised. Wien Klin Wochenschr. 2016; 128(21-22):796-801. PMC: 5104815. DOI: 10.1007/s00508-016-1083-9. View

17.

Wang H, Yang C, Chiou T, Yang S, Gau J, Yu Y . Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection. Hematol Oncol. 2016; 35(4):835-844. DOI: 10.1002/hon.2333. View

18.

Khadanga S, Solomon B, Dittus K . Hemophagocytic Lymphohistiocytosis (HLH) Associated with T-Cell Lymphomas: Broadening our Differential for Fever of Unknown Origin. N Am J Med Sci. 2014; 6(9):484-6. PMC: 4193158. DOI: 10.4103/1947-2714.141656. View

19.

Dhadwad J, Kadiwala R, Modi K, Yadav P, Vadivel S . A Case of Pyrexia of Unknown Origin Diagnosed as Hemophagocytic Lymphohistiocytosis. Cureus. 2024; 16(2):e53553. PMC: 10913697. DOI: 10.7759/cureus.53553. View

20.

Abdelhay A, Mahmoud A, Al Ali O, Hashem A, Orakzai A, Jamshed S . Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006-19: a national, retrospective cohort study. EClinicalMedicine. 2023; 62:102143. PMC: 10432999. DOI: 10.1016/j.eclinm.2023.102143. View